A study on the effects of culture supernatant of human somatic stem cells on diabetes mellitus

A study on the effects of culture supernatant of human somatic stem cells on diabetes mellitus - The effects of culture supernatant of human stem cells on diabetes mellitus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015554

Enrollment

Registered

2014-10-28

Start date

2014-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus

Interventions

Intravenous or intranasal administration of culture supernatant of human somatic stem cells

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with diabetes mellitus under treatment Treatment has not been changed in the previous month and it is anticipated that the treatment will not be changed in the next month Patients with abnormal HbA1c

Exclusion criteria

Exclusion criteria: Patients with malignant diseases

Design outcomes

Primary

Measure	Time frame
Safety: Adverse events and laboratory tests	—

Secondary

Measure	Time frame
Efficacy: Clinical symptoms and laboratory tests	—

Countries

Japan

Contacts

Public ContactHiroshi Terunuma

Southern TOHOKU Research Institute for Neuroscience Clinical research center for regeneration factor

terunuma.h@gmail.com024-934-5322

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026